Noriyuki Sato

This inventor holds 18 USPTO granted patents, plus 1 CIPO patent and 3 EPO patents, primarily in Cancer Treatment. Top assignees: Toyo Suisan Kaisha, Ltd., Sapporo Medical University, Ajinomoto Co., Ltd.. Active years: 1998-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Noriyuki Sato. Retrieved from https://idiyas.com/inventor/noriyuki-sato-ujqc5a9z

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 18

% Patents Active = 44.4

CIPO Patents = 1 (Patent Applications = 2)

EPO Patents = 3

Average Co-Inventor Count = 7.4

ph-index = 4

Forward Citations = 40(Granted Patents)

Location History:

Shizuoka-ken, JP (2003)
Sapporo-shi, Hokkaido, JP (2010)
Sapporo, JP (1998 - 2021)

Company Filing History:

8 out of 25

Toyo Suisan Kaisha, Ltd.

patents

3 out of 36

Sapporo Medical University

Dainippon Sumitomo Pharma Co., Ltd.

patents

5. 2 out of 110

Sumitomo Dainippon Pharma Co., Ltd.

patents

6. 1 out of 43

Medical Biological Laboratories Co., Ltd.

patents

7. 6 out of 834,659

Other

patents

where one patent can have more than one assignee

Years Active: 1998-2021

Loading Chart...

Areas of Expertise:

Tumor Antigen Peptide

Cancer Treatment

Sulfonated Sugar Compounds

Immunosuppressive Agent

HLA-A24 Binding Peptide

Gastric Cancer Antigen

Sulfopyranosylacylglycerol

Peptide Inducing Immune Response

Medicaments

Pharmaceutical Compositions

Cancer Antigen Protein

Sulfofucosylacylglycerol

18 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11028136 - Tumor antigen peptide (2021-06-08),

2. 10765729 - Tumor antigen peptide (2020-09-08),

3. 9260499 - Tumor antigen peptide and use thereof (2016-02-16),

4. 7973145 - Sulfonated sugar compounds, pharmaceutical compositions which contain the same, and methods of treating tumors with the same (2011-07-05),

5. 7700108 - Tumor antigen protein and use thereof (2010-04-20),

6. 7601801 - HLA-A24 binding cancer antigen peptide derived from livin (2009-10-13),

7. 7378398 - Method for treating cancer (2008-05-27),

8. 7148200 - Method for treating cancer (2006-12-12),

9. 7030222 - Human gastric cancer antigen gene and gastric cancer antigen protein (2006-04-18),

10. 6919316 - Immunosuppressive agent (2005-07-19),

11. 6770629 - Administration of a sulfopyranosylacylglycerol to treat certain cancers (2004-08-03),

12. 6759522 - Sulforhamnosylacyglycerol derivatives and use thereof as medicaments (2004-07-06),

13. 6740640 - Sulfofucosylacylglycerol derivatives and administration thereof as medicaments (2004-05-25),

14. 6575198 - Method of connecting two elongated portions of metallic plate, method of manufacturing exhaust pipe of two-passage construction, and exhaust pipe of two-passage construction (2003-06-10),

15. 6518410 - Sulfoquinovosylacylglycerol derivative, and use thereof as medicaments (2003-02-11),

Title: The Innovative Mind of Noriyuki Sato: Pioneering Cancer Research

Introduction

Noriyuki Sato, based in Sapporo, Japan, is an accomplished inventor with a remarkable portfolio of 18 patents. His work primarily focuses on advancements in cancer research, particularly in the development of tumor antigen peptides that have significant implications for cancer prevention and treatment.

Latest Patents

Sato's most recent patents include cutting-edge discoveries aimed at targeting cancer stem cells through innovative tumor antigen peptides. These peptides are crucial for identifying and treating cancers more effectively. One of his inventions details a tumor antigen peptide that is specifically presented on cancer and cancer stem cells, providing a pharmaceutical composition that contains this peptide as an active ingredient for cancer prevention and treatment. Furthermore, he has developed a detection agent specifically designed to identify cancer stem cells, along with a medicinal composition that relies on these tumor antigen peptides to combat cancer. His inventions also encompass methods for screening these peptides, enhancing the tools available for cancer research.

Career Highlights

Throughout his career, Noriyuki Sato has worked with notable companies such as Toyo Suisan Kaisha, Ltd. His contributions to the field are marked by his dedication to improving cancer treatment methodologies and enhancing the understanding of cancer biology through his patented innovations.

Collaborations

Sato has collaborated with esteemed colleagues, including Hiroeki Sahara and Takayuki Yamazaki. These partnerships have undoubtedly enriched the scope and impact of his research, fostering innovation in the fight against cancer.

Conclusion

Noriyuki Sato's inventive spirit and unwavering commitment to cancer research through his 18 patents exemplify the role of innovation in improving medical treatments. His ongoing contributions are sure to leave a lasting impact on the field of oncology and beyond.

Profile summary based on public USPTO records.